Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
A comparison of the CHARGE–AF and the CHA2DS2-VASc risk scores for prediction of atrial fibrillation in the Framingham Heart Study — Ingrid E. Christophersen (2016) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
A comparison of the CHARGE–AF and the CHA2DS2-VASc risk scores for prediction of atrial fibrillation in the Framingham Heart Study
Shared by
Emelia Benjamin
A comparison of the CHARGE–AF and the CHA2DS2-VASc risk scores for prediction of atrial fibrillation in the Framingham Heart Study
Article
2016
en
Authors
+5 more
IC
Ingrid E. Christophersen
XY
Xiaoyan Yin
ML
Martin G. Larson
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2015
Abstract 12125: The CHARGE-AF Risk Score Performs Better at Predicting Risk of Atrial Fibrillation than the CHA2DS2-VASc Risk Score in the Framingham Heart Study
Ingrid E. Christophersen
,
Xiaoyan Yin
,
Martin G. Larson
,
Steven A. Lubitz
,
Jared W. Magnani
,
David D. McManus
,
Patrick T. Ellinor
,
Emelia Benjamin
Article
2020
Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores
José Miguel Rivera‐Caravaca
,
Marco Proietti
,
María Asunción Esteve‐Pastor
,
Francisco Marı́n
,
Professor Gregory Lip
Article
2024
CHA2DS2-VASc or a non-sex score (CHA2DS2-VA) for stroke risk prediction in atrial fibrillation: contemporary insights and clinical implications
Professor Gregory Lip
,
Konsta Teppo
,
Peter Brønnum Nielsen
Article
2025
Stroke risks in women vs men in Asian patients with atrial fibrillation: A temporal trend analysis and a comparison of the CHA2DS2-VASc and CHA2DS2-VA stroke risk stratification scores
Wen‐Han Cheng
,
Yi‐Hsin Chan
,
Ling Kuo
,
Jo‐Nan Liao
,
Chih‐Min Liu
,
Shih‐Ann Chen
,
Professor Gregory Lip
Article
2020
Thromboembolic risk in non-anticoagulated atrial fibrillation patients with valvular heart disease and low CHA2DS2-VASc scores: are these patients truly low risk of stroke?
Line Melgaard
,
Thure Filskov Overvad
,
Martin Jensen
,
Professor Gregory Lip
,
Torben Bjerregaard Larsen
,
Peter Brønnum Nielsen
Discussion(0)
No comments yet. Be the first to comment.